Harpreet Singh, Immatics CEO

Im­mat­ics imag­ines broad­er CAR-T pipeline with an­oth­er Bris­tol My­ers pact and ad­di­tion to 2019 TCR deal

Im­mat­ics is hit­ting the gas ped­al on an­oth­er Bris­tol My­ers Squibb deal as the biotech-Big Phar­ma pair al­so lev­el up their 2019 pact, orig­i­nal­ly inked …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA